Nuena, Ronald .

HRN: 20-75-63  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/27/2024
CO-AMOXICLAV 625MG (TAB)
02/27/2024
03/05/2024
ORAL
625 Mg
Every 12 Hours
S/P Mesh Hernioplasty
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft TissueIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: